Home » Topics » Disease categories and therapies » Substance use and poisoning

Substance use and poisoning
RSS

Embera begins phase II study of EMB-001 for cocaine use disorder

Sep. 1, 2020

FDA clears IND for phase II study of TNX-102 SL

Aug. 7, 2020

Indivior begins first-in-human study of INDV-2000 for opioid dependence

July 9, 2020

Idorsia Pharmaceuticals identifies new Ox1-R and Ox2-R antagonists

June 4, 2020

Estrogen and dopamine

June 4, 2020

New alcohol risk genes in Caucasians

June 2, 2020

A new oxime that crosses the blood-brain barrier as a treatment for organo-phosphate poisoning

May 25, 2020

New MVP against SVMP

May 11, 2020

Antibiotics affect oxycodone effects

May 8, 2020

Platelets play role in Tylenol toxicity

April 30, 2020

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 23, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for April 21, 2026
Psychedelic space expanding on Trump’s EO
BioWorld
Timothy Leary is dead, but he could be on the outside looking in with a smile on his face as U.S. President Donald Trump’s latest executive order (EO) fuels a...
At AACR: Epigenetic fingerprints in metastases track tumor origin
BioWorld
When a tumor migrates and colonizes another tissue or organ, it can be identified as a metastasis, but its origin is not always clear. Now, a study based on...
In the clinic for April 21, 2026
BioWorld
Clinical updates for biopharma and med tech, including data readouts and publications: Abbott, Agenus, Astrazeneca, Briacell, Clearmind, Greenwich, Intodna,...